Novo Nordisk slashing prices for weight-loss and diabetes drugs Ozempic, Wegovy and Rybelsus

Novo Nordisk announced Tuesday it volition beryllium slashing the database terms of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent opening adjacent year. Starting connected Jan. 1, 2027, the database terms for Wegovy, Ozempic and Rybelsus, Novo’s semaglutide products, volition beryllium $675 crossed the committee successful the U.S. This reduction…